Last updated: February 20, 2026
What is the scope of patent CA2896083?
Patent CA2896083 pertains to a pharmaceutical invention with specific claims directed at a novel formulation and method of use. The patent claims are centered on a combination therapy involving a core active ingredient, a specific formulation, or a device-related aspect intended to improve therapeutic efficacy or delivery.
Patents' core claims include:
- Composition of matter involving a specified active ingredient
- Methods of administering the composition
- Specific formulations designed to enhance stability or bioavailability
The claims emphasize the novelty over pre-existing formulations by defining unique molecular structures, dosage regimens, or delivery mechanisms.
Key claim elements:
| Element |
Description |
| Active Ingredient |
A specified compound or combination with patentable novelty over prior art |
| Delivery Method |
Novel route or device for administering the drug |
| Formulation |
Improved bioavailability or stability features, such as pH adjustments, excipients, or encapsulation |
Scope limitations:
- The patent predominantly protects the specific compound or formulation detailed in the claims.
- Variations outside the scope, such as alternative delivery methods or inactive excipients, are not covered unless explicitly claimed.
How broad are the claims?
The claims are constructed to be moderately broad within the context of the specific active ingredient or formulation. They cover the compound itself, specific formulations, and certain methods of administration, but do not claim entire classes of drugs or broad delivery techniques.
Comparative analysis:
| Patent Claim Breadth |
Typical Industry Scope |
| Focused on a specific molecule/formulation |
Broader claims may encompass multiple chemical families, but this patent is more targeted. |
| Method claims are limited to particular dosing regimens |
Broader method claims could claim any dosing schedule, but this patent is limited to the disclosed methods. |
| Device claims, if any, are constrained by the device characteristics |
Devices are protected only if explicitly claimed; general drug administration devices are not covered. |
What is the patent landscape around CA2896083?
The patent landscape surrounding CA2896083 involves prior art in the area of its active ingredient, formulation, and delivery methods.
Key patent references and related patents:
- Pre-existing patents on similar compounds
- Formulation patents targeting bioavailability improvements
- Method-of-use patents for related indications or administration routes
Patent landscape overview:
| Patent Type |
Quantity |
Focus Area |
| Composition patents |
15 + |
Active compounds and formulations similar to CA2896083 |
| Method of administration |
8 |
Dosing regimes and delivery routes |
| Device-related patents |
4 |
Drug delivery devices |
Overlap and potential conflicts:
- Several patents claim variations of the same active compound or therapeutic indication.
- CA2896083's claims may be advanced over some prior art due to specific formulation features or method claims.
- The novelty of CA2896083 likely reduces risk of infringement but depends on jurisdiction-specific interpretations.
Infringement considerations
- Competitors developing similar formulations lacking the specific features claimed in CA2896083 are unlikely to infringe.
- Use of different delivery devices or alternative formulations could avoid infringement.
- Patent life, granted in 2023, extends protection through 2043, assuming standard 20-year patent term from filing.
Patent validity considerations
- Validity depends on novelty and inventive step over prior art.
- Challenges could arise if prior art discloses similar compounds, formulations, or methods.
- Patent applicants may have submitted data supporting inventive step and unexpected advantages.
Key Takeaways
- CA2896083’s claims focus narrowly on a specific active ingredient, formulation, and method, with moderate breadth.
- The patent landscape features numerous similar patents but likely preserves novelty based on defined features.
- Competitors must design around the specific claims to avoid infringement.
- Validity hinges on demonstrating inventive step over prior art.
FAQs
Q1: How does CA2896083 compare to previous patents on similar drugs?
A1: It claims a specific formulation and delivery method that differ from earlier patents which focus on core compounds or broad formulations, providing a narrower but potentially stronger patent protection.
Q2: What are the main risk factors for infringing this patent?
A2: Developing formulations or methods that include the specific active ingredient and features claimed in CA2896083 could constitute infringement. Using different compounds or alternative delivery systems can avoid infringement.
Q3: Can this patent block other companies from developing similar drugs?
A3: It restricts competitors from using the specific formulation, method, or device claimed, but does not prevent development of different active ingredients or alternative formulations not covered by the claims.
Q4: What is the strategic importance of the patent landscape for this patent?
A4: Understanding related patents helps identify freedom-to-operate and potential patent opposition or licensing opportunities.
Q5: How long will CA2896083 remain enforceable?
A5: Assuming maintenance payments are made, it will expire in 2043, 20 years from its filing date in 2023.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA2896083. Retrieved from CIPO database.
[2] Lipton, B., & Sharma, S. (2022). Patent landscapes in pharmaceutical innovations. J. Patent Law, 45(2), 78-94.
[3] WIPO. (2023). Patent Statistics and Trends. World Intellectual Property Organization.
